Current trends in management of hepatitis B virus reactivation in the biologic therapy era

doi:10.3748/wjg.v17.i34.3881

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 34

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10930)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

662

HTML

9886

Figures (1-2)

382

Sum=10930

Sep 14, 2011 (publication date) through Jan 2, 2025

Times Cited of This Article

Times Cited (38)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Sep 14, 2011; 17(34): 3881-3887
Published online Sep 14, 2011. doi: 10.3748/wjg.v17.i34.3881

Full Size Figure Download Figure

Figure 2 Proposed algorithm for the management of hepatitis B virus-infected patients requiring biologic therapy. HBV: Hepatitis B virus; TNF-α: Tumor necrosis factor α; HbsAg: HBV surface antigen; HBcAb: Hepatitis B core antibody; HBsAb: Hepatitis B surface antibody; ALT: Alanine transaminase; AST: Aspartate transaminase.

Citation: Mastroianni CM, Lichtner M, Citton R, Borgo CD, Rago A, Martini H, Cimino G, Vullo V. Current trends in management of hepatitis B virus reactivation in the biologic therapy era. World J Gastroenterol 2011; 17(34): 3881-3887
URL: https://www.wjgnet.com/1007-9327/full/v17/i34/3881.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i34.3881